Education
About Us
Working with TipRanks
Follow Us
10X Fund, L.P. Insider Profile
4 Followers
10X Fund, L.P., Ten Percent Owner at Galectin Therapeutics, holds 5.83M shares in Galectin Therapeutics (Ticker: GALT). Most recently, 10X Fund, L.P. Sold 40,000 shares of Galectin Therapeutics on Nov 12, 2025 for an estimated value of $210.00K.
10X Fund, L.P. Galectin Therapeutics (GALT)Ten Percent Owner
Galectin Therapeutics (GALT)
Ten Percent Owner
Ranked #75,517 out of 104,104 Corporate Insiders
Profitable Transactions
6 out of 11 Profitable Transactions
Average Return
-9.10%
Average return per transaction
Time Frame
Compare to
Insider Roles
Ten Percent Owner
Roles that 10X Fund, L.P. holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Oct 19, 2021 - Oct 19, 2022
Return:+53.60%
The most profitable trade made by 10X Fund, L.P.
10X Fund, L.P.'s Trading History
List of latest transactions for each holding click on a transaction to see 10X Fund, L.P.'s performance on stock
You May Also Like
10X Fund, L.P. insider profile FAQ
What is the percentage of profitable transactions made by 10X Fund, L.P.?
The percentage of profitable transactions made by 10X Fund, L.P. is 55%.
What is the average return per transaction made by 10X Fund, L.P.?
The average return per transaction made by 10X Fund, L.P. is -9.10%.
What stocks does 10X Fund, L.P. hold?
10X Fund, L.P. holds: GALT stocks.
What was 10X Fund, L.P.’s latest transaction?
10X Fund, L.P. latest transaction was an Informative Sell of $210.00K.
What was 10X Fund, L.P.'s most profitable transaction?
10X Fund, L.P.’s most profitable transaction was an Informative Sell of GALT stock on October 19, 2021. The return on the trade was 53.60%.
What is 10X Fund, L.P.'s role in Galectin Therapeutics?
10X Fund, L.P.'s role in Galectin Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.